enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. 25 Belt-Busting Obesity Facts - AOL

   www.aol.com/news/2013-05-18-25-belt-busting...

   The Food and Drug Administration approved the weight-loss therapy Belviq from Arena Pharmaceuticals in June 2012. It took nearly one year for the company to gain marketing approval, but Belviq's ...

3. Lorcaserin - Wikipedia

   en.wikipedia.org/wiki/Lorcaserin

   Lorcaserin, marketed under the brand name Belviq, [4] [5] was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating serotonin receptor the 5-HT 2C receptor in the hypothalamus , a region of the brain which is known to control appetite. [ 6 ]

4. New Obesity Drug Hits the Market - AOL

   www.aol.com/news/2013-06-07-new-obesity-drug...

   For premium support please call: 800-290-4726 more ways to reach us

5. 5 new weight-loss drugs to watch in the fight for the next ...

   www.aol.com/5-weight-loss-drugs-watch-104701179.html

   GLP-1 medications are breakthroughs for weight loss, diabetes, and more. Pharma companies are clamoring to produce pills or longer-lasting drugs with faster effects. Novo Nordisk, Eli Lilly ...

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   The United States Food and Drug Administration and the European Medicines Agency have approved weight loss medications for adults with either a body-mass index (BMI) of at least 30, or a body-mass index of at least 27 with at least one weight-related comorbidity. This patient population is considered to have sufficiently high baseline health ...

7. The Good News, Bad News for Belviq: Bad News First... - AOL

   www.aol.com/2013/11/21/the-good-news-bad-news...

   Arena Pharmaceuticals and its lead product, weight loss drug Belviq, have had a difficult run since Belviq's launch in June. On its recent conference call, Arena's marketing partner Eisai reported ...